Press Releases

Press Releases

Home › Investors › Press Releases

OncoSec to Host First Quarter Financial Results Conference Call on December 8, 2015

November 19, 2015

OncoSec Medical Closes $7.5 Million Registered Direct Offering

November 9, 2015

OncoSec Announces $7.5 Million Registered Direct Offering

November 3, 2015

OncoSec Enrolls First Patient in Biomarker-Focused Pilot Study in Triple Negative Breast Cancer

October 29, 2015

OncoSec Issues Annual Letter To Shareholders

October 27, 2015

OncoSec Announces Fourth Quarter and YTD Results for Fiscal Year End 2015

October 14, 2015

OncoSec to Present at Investment Conferences in October

October 5, 2015

OncoSec to Host Fourth Quarter Financial Results Conference Call and Live Webcast on October 15, 2015

October 1, 2015

OncoSec Announces Positive Results from Phase II Trial of ImmunoPulse™ IL-12 in Merkel Cell Carcinoma

September 27, 2015

OncoSec Appoints David P. Meininger, PhD, MBA, as Senior Vice President of Business Development

September 14, 2015

Copyright © 2017 OncoSec Medical. All Rights Reserved. Q12-003052-01 REV E